BIO-key International (NASDAQ:BKYI) Share Price Crosses Above Fifty Day Moving Average – What’s Next?
by Scott Moore · The Cerbat GemBIO-key International Inc. (NASDAQ:BKYI – Get Free Report) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.61 and traded as high as $0.70. BIO-key International shares last traded at $0.6455, with a volume of 1,965,663 shares traded.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Wednesday, January 21st. Wall Street Zen raised shares of BIO-key International to a “sell” rating in a research note on Saturday, January 3rd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.
View Our Latest Research Report on BIO-key International
BIO-key International Stock Performance
The company has a 50 day moving average of $0.61 and a two-hundred day moving average of $0.68. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The company has a market capitalization of $7.00 million, a PE ratio of -0.92 and a beta of 0.50.
BIO-key International (NASDAQ:BKYI – Get Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The technology company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.12). BIO-key International had a negative net margin of 75.32% and a negative return on equity of 67.43%. The firm had revenue of $1.24 million for the quarter, compared to analysts’ expectations of $2.20 million.
Hedge Funds Weigh In On BIO-key International
An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its holdings in shares of BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is currently owned by institutional investors.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.